Reduced ability to neutralize the Omicron variant among adults after infection and complete vaccination with BNT162b2, ChAdOx1, or CoronaVac and heterologous boosting. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-023-34035-9
PubMed Identifier: 37156846
Publication URI: http://europepmc.org/abstract/MED/37156846
Type: Journal Article/Review
Volume: 13
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322